Trademark: 87263365
Word
ALYMBRIS
Status
Dead
Status Code
606
Status Date
Monday, July 23, 2018
Serial Number
87263365
Mark Type
4000
Filing Date
Friday, December 9, 2016
Published for Opposition
Tuesday, April 25, 2017
Abandoned Date
Monday, July 23, 2018

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, psychiatric disorders, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Trademark Events
Jul 23, 2018
Abandonment Notice Mailed - No Use Statement Filed
Jul 23, 2018
Abandonment - No Use Statement Filed
Dec 1, 2017
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2017
Extension 1 Granted
Nov 21, 2017
Extension 1 Filed
Nov 27, 2017
Case Assigned To Intent To Use Paralegal
Nov 21, 2017
Teas Extension Received
Jun 21, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 25, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 25, 2017
Published For Opposition
Apr 5, 2017
Notification Of Notice Of Publication E-Mailed
Mar 14, 2017
Approved For Pub - Principal Register
Mar 13, 2017
Assigned To Examiner
Dec 14, 2016
New Application Office Supplied Data Entered In Tram
Dec 13, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24